---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295691315.md"
description: "AN2 Therapeutics shares are trading higher after the company reported better-than-expected Q2 EPS results."
datetime: "2026-08-12T15:34:37.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295691315.md)
  - [en](https://longbridge.com/en/news/295691315.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295691315.md)
generator: "portal-rs"
---

# 

AN2 Therapeutics shares are trading higher after the company reported better-than-expected Q2 EPS results.

### Related Stocks

- [ANTX.US](https://longbridge.com/en/quote/ANTX.US.md)

## Related News & Research

- [Anthem (NASDAQ:ANTX) Director Robin Shane Readnour Sells 6,100 Shares of Stock](https://longbridge.com/en/news/298381637.md)
- [AN2 Therapeutics director Margaret M. FitzPatrick acquires 2,098 common shares worth $11,602.94](https://longbridge.com/en/news/297838611.md)
- [REG - T.Rowe Price Assoc Prologis, Inc. - Form 8.3 - Prologis Inc](https://longbridge.com/en/news/298928545.md)
- [REG - 55I, LLC Prologis, Inc. - Form 8 (DD)-Prologis Inc](https://longbridge.com/en/news/298905029.md)
- [REG - Barclays PLC Prologis, Inc. - Form 8.3 PROLOGIS, INC.](https://longbridge.com/en/news/299048592.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**